首页> 外文OA文献 >Synthesis, spectroscopic characterization and radiosensitizing properties of acetato-bridged copper(II) complexes with 5-nitroimidazole drugs
【2h】

Synthesis, spectroscopic characterization and radiosensitizing properties of acetato-bridged copper(II) complexes with 5-nitroimidazole drugs

机译:醋酸 - 桥联铜(II)配合物与5-硝基咪唑类药物的合成,光谱表征和放射增敏特性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Three novel acetato-bridged dinuclear copper(II) complexes with 5-nitroimidazoles (CuAcNtrim) and the known copper-acetato-metronidazole have been prepared by an environment-friendly route and spectroscopically characterized. The CuAcNtrim compounds of formula [Cu(2)(mu-O(2)CCH(3))(4)Ntrim(2)], where Ntrim = metronidazole (1), secnidazole (2), tinidazole (3) or nimorazole (4), exhibit dimeric copper-acetato paddle-wheel structures with Ntrim axial ligands coordinated to copper(II) ions through the N(3) atoms of the imidazole rings. EPR data indicate antiferromagnetic behavior for this novel series of copper complexes. The constant coupling has been found to decrease along with the increasing of basicity of the Ntrim axial ligand. The CuAcNtrim complexes and the correspondent Ntrim parent drugs have shown radiosensitizer properties for Hep2 (human larynx cancer) cell line in vitro. The best enhancement of radiosensitizer activity upon coordination of the Ntrim drug to copper(II) has been found for the nimorazole compound which has the strongest Cu-Ntrim bond and exhibits the highest lipophilicity within the series of CuAcNtrim complexes. (C) 2010 Elsevier B.V. All rights reserved.
机译:通过环境友好的方法制备了三种新型的乙酰桥联双核铜(II)与5-硝基咪唑(CuAcNtrim)和已知的铜乙酰甲硝唑配合物并进行了光谱表征。式[Cu(2)(mu-O(2)CCH(3))(4)Ntrim(2)]的CuAcNtrim化合物,其中Ntrim =甲硝唑(1),替硝唑(2),替硝唑(3)或尼莫拉唑(4)展示具有Ntrim轴向配体的二聚体铜-乙酰胺桨叶结构,该配体通过咪唑环的N(3)原子与铜(II)离子配位。 EPR数据表明该新颖系列的铜配合物的反铁磁行为。已经发现,恒定的偶联随着Ntrim轴向配体的碱性的增加而降低。 CuAcNtrim复合物和相应的Ntrim母体药物在体外显示出对Hep2(人喉癌)细胞系的放射增敏特性。对于具有最强的Cu-Ntrim键且在CuAcNtrim配合物系列中表现出最高亲脂性的尼莫拉唑化合物,发现在Ntrim药物与铜(II)配位后,放射增敏剂活性得到最佳增强。 (C)2010 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号